Immunotherapy combination shows unprecedented results in multiple myeloma

10th December 2025 Uncategorised 0

MajesTEC-3 study supports teclistamab plus daratumumab SC as potential standard of care

More: Immunotherapy combination shows unprecedented results in multiple myeloma
Source: News